George Scangos' Bold Vision Post author:Sam Post published:October 24, 2017 Post category:BioPharma The former Biogen CEO is making waves at his new venture, Vir Biotechnology. Source: BioSpace You Might Also Like PTC Therapeutics To Host Conference Call To Discuss Second Quarter Financial Results July 24, 2017 Adaptimmune Sees Positive Early Results in Cancer Treatment March 15, 2018 Why This Small SoCal Biotech's Pipeline Makes it Flushed for Growth November 28, 2017